The reliability and validity of the simplified Chinese version of Male QUALEFFO-26

详细信息    查看全文

• 作者：Leilei Xu ; Weixiang Sun ; Xiaodong Qin ; Xiufen Zhu ; Yong Qiu…
• 关键词：Osteoporosis ; Validation ; Quality of life ; Questionnaires ; Male
• 刊名：Rheumatology International
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：36
• 期：4
• 页码：489-494
• 全文大小：396 KB
• 参考文献：1.Johnell O, Kanis J, Gullberg G (2001) Mortality, morbidity, and assessment of fracture risk in male osteoporosis. Calcif Tissue Int 69:182–184CrossRef PubMed
  2.Hartmann DM (1997) Morbidity of osteoporosis—Can estrogen use make a public health impact? Curr Opin Obstet Gynecol 9:289–294CrossRef PubMed
  3.Cree MW, Juby AG, Carriere KC (2003) Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int 14:722–727CrossRef PubMed
  4.Frech T, Ma KN, Ferrucci ED et al (2012) Prevalence of fracture and osteoporosis risk factors in American Indian and Alaska Native people. J Health Care Poor Underserved 23:1157–1173CrossRef PubMed
  5.Ahlborg HG, Rosengren BE, Jarvinen TL et al (2010) Prevalence of osteoporosis and incidence of hip fracture in women–secular trends over 30 years. BMC Musculoskelet Disord 11:48CrossRef PubMed PubMedCentral
  6.Wilson S, Sharp CA, Davie MW (2012) Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review. Osteoporos Int 23:2749–2768CrossRef PubMed
  7.Meunier PJ, Roux C, Ortolani S et al (2009) Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 20:1663–1673CrossRef PubMed PubMedCentral
  8.Gosch M, Roth T, Kammerlander C et al (2011) Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation: changes over the last decade. Z Gerontol Geriatr 44:381–386CrossRef PubMed
  9.Gehrig LM, Lane JM, O’Connor MI (2009) Osteoporosis: management and treatment strategies for orthopaedic surgeons. Instr Course Lect 58:817–832PubMed
  10.Salaffi F, Cimmino MA, Malavolta N et al (2007) The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34:1551–1560PubMed
  11.Gold DT (2003) Osteoporosis and quality of life psychosocial outcomes and interventions for individual patients. Clin Geriatr Med 19:271–280CrossRef PubMed
  12.Randell AG, Bhalerao N, Nguyen TV et al (1998) Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire. J Rheumatol 25:1171–1179PubMed
  13.Cook DJ, Guyatt GH, Adachi JD et al (1999) Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int 10:207–213CrossRef PubMed
  14.Lips P, Cooper C, Agnusdei D et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 10:150–160CrossRef PubMed
  15.van Schoor NM, Knol DL, Glas CA et al (2006) Development of the Qualeffo-31, an osteoporosis-specific Quality-of-Life Questionnaire. Osteoporos Int 17:543–551CrossRef PubMed
  16.Lai BM, Tsang SW, Lam CL, Kung AW (2010) Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-31) in Chinese. Clin Rheumatol 29:965–972CrossRef PubMed PubMedCentral
  17.Li WC, Chen YC, Yang RS et al (2013) Taiwanese Chinese translation and validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis 31 (QUALEFFO-31). J Formos Med Assoc 112:621–629CrossRef PubMed
  18.de Oliveira FN, Arthuso M, Da SR, Pinto-Neto AM, Costa-Paiva L (2013) Validation of the Portuguese version of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-41) in Brazilian women with postmenopausal osteoporosis with vertebral fracture. Clin Rheumatol 32:1585–1592CrossRef
  19.Tadic I, Vujasinovic SN, Tasic L et al (2012) Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population. Health Qual Life Outcomes 10:74CrossRef PubMed PubMedCentral
  20.de Oliveira FN, Arthuso M, Da SR et al (2009) Quality of life in women with postmenopausal osteoporosis: correlation between QUALEFFO 41 and SF-36. Maturitas 62:85–90CrossRef
  21.Dy CJ, Lamont LE, Ton QV, Lane JM (2011) Sex and gender considerations in male patients with osteoporosis. Clin Orthop Relat Res 469:1906–1912CrossRef PubMed PubMedCentral
  22.Neuman MD, Kennelly AM, Tosi LL (2011) Breakout session: sex/gender and racial/ethnic disparities in the care of osteoporosis and fragility fractures. Clin Orthop Relat Res 469:1936–1940CrossRef PubMed PubMedCentral
  23.Lentle BC, Brown JP, Khan A et al (2007) Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J 58:27–36PubMed
  24.Wild D, Grove A, Martin M et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104CrossRef PubMed
  25.Li L, Wang HM, Shen Y (2003) Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 57:259–263CrossRef PubMed PubMedCentral
  26.Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428CrossRef PubMed
  27.Solimeo SL, Silverman SL, Calderon AD, Nguyen A, Gold DT (2012) Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQ. Osteoporos Int 23:841–852CrossRef PubMed PubMedCentral
  28.Calasanti T (2010) Gender relations and applied research on aging. Gerontologist 50:720–734CrossRef PubMed
  29.Murrell P, Todd CJ, Martin A et al (2001) Postal administration compared with nurse-supported administration of the QUALEFFO-41 in a population sample: comparison of results and assessment of psychometric properties. Osteoporos Int 12:672–679CrossRef PubMed
  
• 作者单位：Leilei Xu (1)
  Weixiang Sun (1)
  Xiaodong Qin (1)
  Xiufen Zhu (1)
  Yong Qiu (1)
  Zezhang Zhu (1)
  
  1. Department of Spine Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Zhongshan Road 321, Nanjing, 210008, China
  
• 刊物主题：Rheumatology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1437-160X

文摘

The aim of the study was to investigate the reliability and validity of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-26) in male osteoporosis patients from Chinese population. The simplified Chinese version of Male QUALEFFO-26 was translated and adapted on the basis of QUALEFFO-31, which was assigned to the cases and controls together with SF-36. Reliability was assessed using the intra-class correlation coefficient (ICC) and Cronbach’s α. Validity was assessed with Pearson’s correlation analysis between the similar domains of the two questionnaires. Receiver operating characteristics (ROC) curve analysis was carried out to determine the ability of male QUALEFFO-26 to discriminate between cases and controls. The ICC was 0.83 for pain domain, 0.79 for mental domain and 0.81 for physical function. Cronbach’s α of each domain ranged from 0.82 to 0.89. Pearson correlation coefficients indicated significantly high correlations between corresponding domains of QUALEFFO-26 and SF-36, with r ranging from −0.523 to −0.832. ROC analysis showed that all the domains of QUALEFFO-26 were significantly predictive of vertebral deformity, with the values of AUC ranging from 0.68 to 0.84. The simplified Chinese version of Male QUALEFFO-26 was a valid, reliable and repeatable instrument showing favorable psychometric characteristics. The questionnaire can be used in male osteoporosis patients from Chinese population.